MedTrace Logo

Adjustable Compression Wraps (ACW) in Lymphedema

NCT07109674 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2025-08-07

No results posted yet for this study

Summary

Compression therapy based on multilayer compression bandaging and com pression garment use remains the most efficient component of complex physical therapy (CPT) in lymphedema treatment. The proper self-application of compression bandages is generally considered as problematic. Adjustable compression wraps (ACW) have been proposed as an alternative to the commonly used short-stretch bandages for lymphedema. These systems allow easy application and removal for patients. They have been tested in patients with vascular disorders of the lower limbs and can be considered in breast cancer survivors with upper-limb lymphedema.

The objective of this study was to compare the effectiveness, physical functioning and comfort of 2 types inelastic compression: adjustable compression wrap (reduction) and multi-layer compression bandaging at the intensive phase of treatment in advanced upper limb lymphedema among breast cancer survivors.

Conditions

Interventions

DEVICE

adjustable compression device (type circaid® reduction kit, Medi-Bayreuth)

inelastic compression during intensive phase of physical therapy

DEVICE

Comparison of inelastic compression efficiency

The effect of compression on volume reduction, physical functioning, disease-related symptoms and comfort

Sponsors & Collaborators

  • University School of Physical Education, Krakow, Poland

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-03
Primary Completion
2025-02-01
Completion
2025-03-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07109674 on ClinicalTrials.gov